Bioxyne Limited (BXN.AX)
AUD 0.02
(-9.09%)
AUD 0.02
(-9.09%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.59 Million | -841.28 Thousand | -506.81 Thousand | 53.13 Thousand | 48.24 Thousand | -1.39 Million |
| Net Income | -12.79 Million | -1.93 Million | -494.02 Thousand | -495.72 Thousand | -593.09 Thousand | -1.26 Million |
| Depreciation & Amortization | 234.4 Thousand | 109.64 Thousand | 30.72 Thousand | 87.26 Thousand | 193.81 Thousand | 17.88 Thousand |
| Deferred income taxes | - | -623.72 Thousand | -291.86 Thousand | - | - | 207.33 Thousand |
| Stock-based compensation | - | 696.42 Thousand | 99.9 Thousand | - | - | 119.5 Thousand |
| Change in working capital | -2.32 Million | 291.99 Thousand | -130.51 Thousand | 432.73 Thousand | 278.57 Thousand | -326.83 Thousand |
| Other non-cash items | 14.09 Million | 624.34 Thousand | 278.96 Thousand | 28.85 Thousand | 168.95 Thousand | -142.36 Thousand |
| Investing Cash Flow | -492.65 Thousand | 3.96 Million | 26.61 Thousand | -33.66 Thousand | -33.66 Thousand | -172.36 Thousand |
| Investments in PPE | -492.65 Thousand | -56.63 Thousand | -60.06 Thousand | -33.66 Thousand | -33.66 Thousand | -63.66 Thousand |
| Acquisitions | - | 4.02 Million | 86.67 Thousand | - | - | -108.69 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -314.18 Thousand | - | - | - | - | - |
| Financing Cash Flow | 1.21 Million | 947.16 Thousand | 493.24 Thousand | -46.78 Thousand | -52.32 Thousand | - |
| Debt repayment | - | -365.03 Thousand | -493.24 Thousand | -46.78 Thousand | -52.32 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.35 Million | 582.13 Thousand | - | - | - | - |
| Other Financing Activities | -139.93 Thousand | 365.03 Thousand | 493.24 Thousand | -46.78 Thousand | -52.32 Thousand | - |
| Accounts receivables | -1.21 Million | -595.49 Thousand | -265.58 Thousand | 15.68 Thousand | 483.56 Thousand | -241.89 Thousand |
| Accounts payables | 37.36 Thousand | 1.8 Million | 210.61 Thousand | 18.62 Thousand | -150.66 Thousand | 100.39 Thousand |
| Inventory | -1.14 Million | -919.25 Thousand | -75.55 Thousand | 398.42 Thousand | -54.32 Thousand | -84.93 Thousand |
| Other working capital | - | - | - | 1.00 | - | -100.39 Thousand |
| Cash at beginning of period | 3.84 Million | 65.93 Thousand | 1.6 Million | 1.74 Million | 1.76 Million | 3.3 Million |
| Cash at end of period | 1.02 Million | 3.84 Million | 65.93 Thousand | 1.6 Million | 1.74 Million | 1.76 Million |
| Capital Expenditure | -492.65 Thousand | -56.63 Thousand | -60.06 Thousand | -33.66 Thousand | -33.66 Thousand | -63.66 Thousand |
| Effect of forex changes on cash | 24.57 Thousand | 1709.00 | -8516.00 | -152.02 Thousand | 13.9 Thousand | 20.73 Thousand |
| Net cash flow / Change in cash | -2.81 Million | 3.78 Million | -1.53 Million | -145.67 Thousand | -20.02 Thousand | -1.54 Million |
| Free Cash Flow | -4.08 Million | -897.92 Thousand | -566.87 Thousand | 19.47 Thousand | 14.58 Thousand | -1.45 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.79 Million | -514.31 Thousand | -12.28 Million | -1.93 Million | -1.96 Million | 23.22 Thousand |
| Depreciation & Amortization | 234.4 Thousand | - | - | 109.64 Thousand | 109.64 Thousand | - |
| Deferred income taxes | - | - | - | -623.72 Thousand | 708.67 Thousand | - |
| Stock-based compensation | - | - | 57.62 Thousand | 696.42 Thousand | 696.42 Thousand | 507.12 Thousand |
| Change in working capital | -2.32 Million | - | - | 291.99 Thousand | -1.51 Million | - |
| Other non-cash items | 14.09 Million | -868.55 Thousand | 10.07 Million | 624.34 Thousand | 1.53 Million | -437.43 Thousand |
| Investing Cash Flow | -492.65 Thousand | -477.31 Thousand | -15.34 Thousand | 3.96 Million | 2.96 Million | 1 Million |
| Investments in PPE | -178.47 Thousand | -163.12 Thousand | -15.34 Thousand | -56.63 Thousand | -56.63 Thousand | -27.2 Thousand |
| Acquisitions | - | - | - | 4.02 Million | 4.02 Million | 141.81 Thousand |
| Investment purchases | - | - | - | - | -3.02 Million | - |
| Sales/Maturities of investments | - | - | - | - | -1 Million | 1 Million |
| Other Investing Activities | -314.18 Thousand | -314.18 Thousand | - | - | -1 Million | -114.6 Thousand |
| Financing Cash Flow | 1.24 Million | 1.24 Million | 3.84 Million | 947.16 Thousand | -52.83 Thousand | 1 Million |
| Debt repayment | - | - | - | -365.03 Thousand | - | -243.82 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -417.86 Thousand | - |
| Common Stock Issuance | 1.35 Million | 1.35 Million | - | 582.13 Thousand | -417.86 Thousand | 1 Million |
| Other Financing Activities | - | - | - | 365.03 Thousand | 365.03 Thousand | 575.71 Thousand |
| Accounts receivables | -1.21 Million | - | - | -595.49 Thousand | -595.49 Thousand | - |
| Accounts payables | 37.36 Thousand | - | - | 1.8 Million | - | - |
| Inventory | -1.14 Million | - | - | -919.25 Thousand | -919.25 Thousand | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3.84 Million | 1.52 Million | 3.84 Million | 65.93 Thousand | 3.79 Million | 2.16 Million |
| Cash at end of period | 1.02 Million | 1.02 Million | 1.52 Million | 3.84 Million | 3.84 Million | 3.79 Million |
| Capital Expenditure | -178.47 Thousand | -163.12 Thousand | -15.34 Thousand | -56.63 Thousand | -56.63 Thousand | -27.2 Thousand |
| Effect of forex changes on cash | - | - | -93.92 Thousand | 1709.00 | -37.63 Thousand | 44.25 Thousand |
| Net cash flow / Change in cash | -2.81 Million | -497.52 Thousand | -2.32 Million | 3.78 Million | 52.82 Thousand | 1.62 Million |
| Free Cash Flow | -3.77 Million | -1.54 Million | -2.22 Million | -897.92 Thousand | -483.71 Thousand | -441.41 Thousand |
OLIV
1354
6645
ARM
WBC
2250